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 1 
Abstract 26 
 27 
Although paediatric patients frequently suffer from intoxications with atypical antipsychotics, the number of studies in 28 
young children, which have assessed the effects of acute exposure to this class of drugs is very limited. The aim of this 29 
study was to achieve a better characterization of the acute toxicity profile in young children of the atypical 30 
antipsychotics clozapine, olanzapine, quetiapine, and risperidone. We performed a multicentre retrospective analysis of 31 
cases with atypical antipsychotics intoxication in children younger than 6 years, reported by physicians to German, 32 
Austrian and Swiss Poisons Centres for the 9-year period between January 1, 2001 and December 31, 2009. One 33 
hundred and six cases (31 clozapine, 29 olanzapine, 12 quetiapine, and 34 risperidone) were available for analysis. 34 
Forty-seven children showed minor, 28 moderate, and 2 severe symptoms. Twenty-nine cases were asymptomatic. No 35 
fatalities were recorded. Symptoms predominantly involved the central nervous and cardiovascular systems. Minor 36 
reduction in vigilance (Glasgow Coma Scale score >9) (62%) was the most frequently reported symptom, followed by 37 
miosis (12%) and mild tachycardia (10%). Extrapyramidal motor symptoms were observed in one case (1%), after 38 
ingestion of risperidone. In most cases, surveillance and supportive care were sufficient to achieve a good outcome, and 39 
all children made full recovery. Conclusions: Paediatric antipsychotic exposure can result in significant poisoning, 40 
however in most cases only minor or moderate symptoms occurred, and were followed by complete recovery. 41 
Symptomatic patients should be monitored for central nervous system depression and an electrocardiogram should be 42 
obtained. 43 
  44 
 2 
Introduction 45 
 46 
Accidental poisoning in children represents a significant cause of paediatric morbidity [2, 5, 20]. According to the latest 47 
Annual Report of the American Association of Poison Control Centres, children under the age of 6 years accounted for 48 
about half of all human intoxications [5], which is comparable to the situation in Switzerland (STIC Annual Report 49 
2012). Additionally, most emergency department visits for intoxication in children involved patients younger than 6 50 
years [30, 22]. Despite prevention efforts like introduction of child-resistant packaging and parental education, 51 
paediatric medication poisoning and emergency department visits after medication exposure is on the rise [6, 4]. 52 
Particularly the number of poisoning with antipsychotic drugs increased remarkably in recent years, with almost 8% 53 
involving children younger than 6 years [13]. 54 
Atypical antipsychotics have become first-line drugs in the treatment of schizophrenia and other common 55 
neuropsychiatric disorders, such as anxiety disorders, bipolar disorders, tic disorders and obsessive compulsive 56 
disorders, because of improved efficacy and side effect profiles, including a lower incidence of extrapyramidal side 57 
effects and tardive dyskinesia [7, 8, 12, 24]. The use of this class of drugs in children and adolescents is increasing, 58 
although frequently in an off-label or unlicensed manner [1, 12, 14, 16, 18, 21, 27, 35]. They currently represent the 59 
most commonly prescribed antipsychotics for young patients [21]. Main indications in children are psychotic and 60 
several nonpsychotic conditions including attention deficit hyperactivity disorder, autism, eating disorders, tic disorders, 61 
and mental retardation associated with behavioural or psychiatric disorders [9, 23]. 62 
The increasing use made atypical antipsychotics more accessible to young children, which are in a stage of mouthing 63 
unknown objects and therefore are especially susceptible to poisoning [25]. Although antipsychotic poisoning has 64 
become a significant cause of morbidity in children, the information available in literature is limited to systematic 65 
reviews based on paediatric therapeutic studies, case reports, isolated case series, expert opinions, or extrapolations 66 
from studies in adults. 67 
The purpose of this study was to achieve a better characterization of the acute toxicity profile in young children of four 68 
common atypical antipsychotics. It should help to improve the management of patients by increasing the amount of 69 
evidence to aid risk estimation of accidental ingestion. 70 
 71 
Methods 72 
 73 
Data acquisition and study design 74 
 75 
 3 
The study was designed as a multicentre retrospective descriptive study of cases with atypical antipsychotics (clozapine, 76 
olanzapine, quetiapine (immediate and extended release) and risperidone) intoxication in children under 6 years of age. 77 
These cases were reported between January 2001 and December 2009 to poisons centres in Austria (Vienna), Germany 78 
(Berlin, Erfurt, Freiburg, Göttingen, Mainz), and Switzerland (Zurich), according to the Codex of the Society of 79 
Clinical Toxicology (GfKT) [32]. The centres were asked to provide the anonymized data in a standardized exchange 80 
spreadsheet format [31]. This data, entered by physicians, included age, sex, weight, ingested drug and dose, 81 
symptoms/signs/laboratory values and causal relationship, severity of intoxication, decontamination measures, latency 82 
to decontamination, and therapeutic interventions. The first author reviewed all cases in detail before they were entered 83 
into the study to ensure that they fulfil the inclusion criteria. Doubts were resolved by consensus in an expert panel 84 
including a senior clinical toxicologist and a clinical pharmacologist with additional qualifications in general internal 85 
medicine. 86 
Since not all centres classify severity of symptoms in the same way, the cases were also re-evaluated according to the 87 
Poisoning Severity Score (PSS) [28], developed by the European Association of Poison Centres and Clinical 88 
Toxicologists, the International Programme on Chemical Safety, and the European Commission. 89 
Ethical approval was obtained from the ethics committees of the participating Poisons Centres and the study has 90 
therefore been performed in accordance with ethical standards. 91 
 92 
Inclusion criteria  93 
 94 
For the reported cases, the following criteria had to be fulfilled to be included in the study: 95 
- monointoxication with either clozapine, olanzapine, quetiapine (immediate and extended release), or risperidone; 96 
- patient age < 6 years; 97 
- follow-up, reported by the treating physician; 98 
- ingested dose known (no dose range was accepted); regardless of dose, accidental ingestion of one of the drugs of 99 
interest was considered an overdose; 100 
- confirmed or likely causal relationship between exposure and clinical effect; causality assessment was based on a clear 101 
temporal relationship between drug ingestion and symptoms, absence of other drugs or diseases that can explain the 102 
symptoms, and the presence of symptoms that are described for the drug in question or are plausible from a 103 
pharmacodynamic point of view; since these criteria could not be used for asymptomatic patients, these cases were 104 
judged according to the ingested dose reported by parents or caregivers. 105 
 106 
Data classification 107 
 4 
 108 
According to the Poisoning Severity Score [28], the severity of symptoms of individual patients was classified as 109 
- ‘minor’ if only mild, transient, and spontaneously resolving symptoms were present 110 
- ‘moderate’ if at least one pronounced or prolonged symptom was recorded and 111 
- ‘severe’ if at least one severe or life-threatening symptom was observed.  112 
The reported symptoms and signs according to their severity are shown in Table 1. 113 
 114 
Statistical Evaluation 115 
 116 
The statistical analysis was performed using the software package R [29]. Descriptive statistics were used to analyse the 117 
data. Correlation between age of patients and number of ingested pills was tested by Spearman rank correlation test. 118 
The Wilcoxon test was used to analyse the association between gender and ingested dose, and the difference between 119 
recorded and estimated body weight. Statistical significance was defined as P < 0.05. 120 
 121 
Results 122 
 123 
During the study period data of 106 children fulfilling inclusion criteria were available for analysis: in 34 (32%) cases 124 
the involved atypical antipsychotic was risperidone, in 31 (29%) clozapine, in 29 (27%) olanzapine, and in 12 (11%) 125 
quetiapine (all of them immediate release tablet formulation). 126 
Because of partially incomplete body weight data, in some cases weight had to be estimated using World Health 127 
Organization (WHO) growth standards charts [34]. There was no significant difference between recorded and estimated 128 
weight (Wilcoxon test p = 0.08). 129 
Baseline characteristics of the patients are summarized in Table 2. There were 43 (41%) females, 52 (49%) males, and 130 
in 11 (10%) cases gender was not reported. The mean age of the patients was 2.6 years (range 0.8−5.5 years; median 2.3 131 
years). No correlation between age and number of ingested pills was found (Spearman correlation coefficient, 0.16; 132 
95% CI, -0.05−0.36). 133 
The number of ingested pills ranged from 0.25 to 8, and 1 pill was ingested in almost half of intoxications (49; 46%), 134 
followed by 0.5 (15; 14%), and 2 (13; 12%). Only 9 (9%) children ingested more than 2 pills. Concerning the number 135 
of ingested pills, there was no significant difference between males and females (Wilcoxon test, p = 0.39). 136 
Neurological and cardiovascular symptoms were predominating. Minor reduction in vigilance (Glasgow Coma Scale 137 
score >9) (66; 62%) was the most frequently reported symptom, followed by miosis (13; 12%) and tachycardia 138 
(>140−<160 bpm) (11; 10%). 139 
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There were 71 (67%) presentations with an admission Glasgow Coma Scale (GCS) score of <15: in 66 (62%) cases 140 
GCS was >9 (1 GCS 11-13; 1 GCS 12; 1 GCS 13 and 63 GCS >9 with no further subdivision), in 4 (4%) GCS was 8-9 141 
and in 1 (1%) GCS was ≤ 7 (GCS 6). Extrapyramidal adverse effects were observed in one girl of 2.8 years after 142 
ingestion of 2 mg (0.1 mg/kg) of risperidone. No extrapyramidal motor symptoms were recorded after the ingestion of 143 
clozapine, olanzapine, or quetiapine. Electrocardiography was performed in 32 (30%) children: 3 (3%) showed 144 
extrasystoles, and in 1 (1%) previously healthy girl aged 1.6 years with potassium value of 3.6 mmol/l, a prolonged 145 
QTc interval (Bazett correction formula) of 468 msec with a heart rate of 136 bpm was recorded after the ingestion of 146 
150 mg (13.6 mg/kg) of quetiapine. The observed symptoms and signs are summarized in Table 3. Gastrointestinal 147 
decontamination with activated charcoal was performed in 49 (46%) children, in 32 (30%) of these within 1 hour of 148 
ingestion. Gastric lavage was performed in 1 single case and 1 case of vomiting induced by parents was reported. 149 
Overall toxicity was rated as severe in 2 (2%), moderate in 28 (26%), and minor in 47 (44%) cases according to the 150 
PSS. 29 (27%) children were asymptomatic (Table 4). No fatalities were recorded.  151 
The toxic dose per kg body weight was estimated as the lowest dose causing objective symptoms or signs. 152 
For clozapine the toxic dose was 0.8 mg/kg, resulting in restlessness, ataxia, dysarthria, and somnolence; for olanzapine 153 
0.4 mg/kg resulting in ataxia and somnolence; for quetiapine 3.1 mg/kg resulting in ataxia and somnolence; and for 154 
risperidone 0.05 mg/kg resulting in somnolence and mild tachycardia. 155 
The management of atypical antipsychotic toxicity mainly consisted of surveillance (64 cases; 60%), cardiovascular and 156 
respiratory monitoring (10; 10%), supportive care with intravenous fluids (2; 2%), potassium substitution (2; 2%), 157 
administration of oxygen (1; 1%), administration of benzodiazepines in case of agitation or tachycardia (2; 2%), and 158 
administration of biperiden in the one case with extrapyramidal side effects (1; 1%). All children showed complete 159 
recovery. 160 
 161 
Discussion 162 
 163 
This study investigated symptoms, signs and severity of clozapine, olanzapine, quetiapine and risperidone intoxication 164 
in children under the age of 6 years. Consistent with the literature, we found a peak incidence of intoxications in 2-year-165 
old toddlers [5, 30, 6]. 166 
Neither a correlation between age and quantity of ingested pills, nor a clear imbalance between gender and occurrence 167 
of intoxication was found. Last mentioned is in contrast to previous studies, reporting a clear male predominance in 168 
childhood poisoning [5, 4]. 169 
Our results demonstrate that accidental poisoning with atypical antipsychotics in children under the age of 6 years, who 170 
in the majority of cases ingested 0.5 to 2 pills, predominantly showed a benign clinical course with no sequelae. This 171 
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finding is in accordance with previous reports [7, 36]. Although a significant number of patients remained 172 
asymptomatic, significant toxicity after ingestion of a single tablet of this class of drugs has been described [20, 7], and 173 
susceptibility for serious toxic effects in children has been postulated [7, 10]. However, it has to be acknowledged that 174 
the reporting of cases with severe symptoms after ingestion of low doses (i.e. publication bias) may be an issue which 175 
might lead to an overestimation of toxicity on the basis of literature data. 176 
Atypical antipsychotic intoxication in children showed the same clinical course as observed in adolescents and adults, 177 
with neurological and cardiovascular symptoms predominating [3, 7, 9, 24]. The toxic dose per kg body weight found in 178 
this study for olanzapine is similar to that described by Isbister et al. [20]. In contrast, for clozapine we found a much 179 
lower toxic dose compared to Isbister et al., which suggests a higher toxicity of this drug in overdose. To our 180 
knowledge, no toxic doses for quetiapine and risperidone have been described previously. 181 
Central nervous system effects were the most common manifestations and ranged from somnolence, apathy and 182 
dysarthria in mild poisoning, to deep coma in severe intoxication [7]. In contrast to adults, in which central 183 
anticholinergic syndrome has been described for quetiapine, no children with such condition were observed in our study 184 
[15]. The fact that somnolence was the most common symptom is not surprising, since somnolence is already a 185 
frequently observed adverse effect in the therapeutic dose range [8, 9, 12, 27]. In accordance with previous reports, 186 
clozapine seems to be the most sedative substance [8, 27]. 187 
Compared with first generation antipsychotic drugs, acute extrapyramidal symptoms (EPS) are less frequent with 188 
atypical antipsychotic drugs [18, 21, 35], but seem to occur more often in children than in adults [12, 21, 17]. They 189 
typically manifest as akathisia, parkinsonism, or dystonic reactions. EPS were frequently reported after poisoning with 190 
risperidone [26], particularly in children [20, 7]. In this study, only one case of EPS resulting from risperidone 191 
poisoning was reported. No EPS were observed after exposure to clozapine, olanzapine and quetiapine, which seem to 192 
have a more favourable EPS profile [7, 8]. 193 
Cardiovascular toxicity is also an uncommon finding in atypical antipsychotic poisoning compared to intoxication with 194 
first generation antipsychotics [7, 33]. Main cardiovascular manifestations are tachycardia, hypotension and 195 
prolongation of the QT interval [33], which are largely an extension of pharmacological effects. In accordance with the 196 
literature [12, 24] and observations in the therapeutic dose range, tachycardia was the most common cardiovascular 197 
symptom in overdose. Although intoxication with atypical antipsychotics has been reported to be associated with ECG 198 
changes and also QT prolongation with the inherent risk of torsades de pointes [35, 33], only minor ECG changes were 199 
recorded in this study, with a single case of moderate prolongation of the QTc interval in a previously healthy child 200 
after exposure to quetiapine, which is probably due to overestimation of the QT by Bazett correction because of 201 
tachycardia [11]. This confirms the rarity of serious cardiovascular effects in atypical antipsychotic poisoning. 202 
Gastrointestinal decontamination with activated charcoal was performed within 1 hour of ingestion in every third child. 203 
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Unfortunately, no analysis of the effect of gastrointestinal decontamination on the severity of the intoxication could be 204 
performed because of low case numbers, heterogeneity of the study population, and absence of a control group. 205 
 206 
Conclusions 207 
 208 
We demonstrated that the majority of children poisoned with the atypical antipsychotic drugs clozapine, olanzapine, 209 
quetiapine, and risperidone had a benign clinical course. Symptoms predominantly involved the central nervous and 210 
cardiovascular systems. Extrapyramidal side effects were rare, and the only case reported was caused by risperidone 211 
intoxication. We identified toxic doses of the four investigated substances, and this may be helpful for the clinician for 212 
risk estimation after accidental ingestion. We recommend to monitor symptomatic patients for central nervous system 213 
depression and to obtain an electrocardiogram with a focus on rhythm disturbances and ECG intervals. 214 
 215 
Study limitations 216 
 217 
This study has a number of limitations, which are primarily related to the retrospective nature of the study design and 218 
the relatively small sample size. Last mentioned is mainly due to our strict inclusion criteria, in particular the decision 219 
to only include monointoxications and cases with well-defined ingested doses, which we are convinced were necessary 220 
to be able to interpret the findings properly, in particular because in most cases we were not able to obtain plasma 221 
concentrations of the investigated substances to confirm the ingested amount. 222 
Larger multicentre series of atypical antipsychotic poisoning in children have, however, not been published to date. 223 
Furthermore, it is likely that not all cases which occurred in the referral population were reported to involved poisons 224 
centres, and that bias toward reporting of the more severe cases occurred. Data are also partially incomplete, which is 225 
the nature of retrospective studies using poison centre data [19]. The use of population data to substitute for missing 226 
body weight data is a clear, but unavoidable, limitation. 227 
Furthermore, the quantities of ingested drugs are estimates derived from the best information provided by the family 228 
member or caregiver and may over- or underestimate the actual ingestion.  229 
Since the majority of our patients ingested low doses of the investigated antipsychotics, the findings can not be 230 
extended to children with larger overdoses. 231 
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